DOA
CLB icon

D'Orazio & Associates’s Core Laboratories CLB Stock Holding History

D'Orazio & Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$1K – 336
2020
Q1 		$1K Hold
100
– – ﹤0.01% 308
2019
Q4 		$4K Hold
100
– – ﹤0.01% 287
2019
Q3 		$5K Buy
+100
New +$4.65K ﹤0.01% 277
2015
Q4 		– Sell
-80
Closed -$9K – 268
2015
Q3 		$9K Buy
+80
New +$8.7K ﹤0.01% 198

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

D'Orazio & Associates's CLB Position: Q2 2020 in Review

D'Orazio & Associates sold out of Core Laboratories (CLB) in Q2 2020, closing a stake of 100 shares — an estimated $1K sold.

D'Orazio & Associates first reported a position in CLB in Q3 2015 and held it in 4 quarters. The position peaked at $9K in Q3 2015. 197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

  • D'Orazio & Associates reported no remaining Core Laboratories position as of Q2 2020 after selling out during the quarter.
  • D'Orazio & Associates sold 100 Core Laboratories shares in Q2 2020, an estimated $1K.
  • D'Orazio & Associates first reported a position in Core Laboratories in Q3 2015 and held it in 4 quarters.
  • D'Orazio & Associates's Core Laboratories position peaked at $9K in Q3 2015.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on D'Orazio & Associates's 13F filing for Q2 2020, filed 22 Jul 2020.